Physician profile
Wade A Neiman
NPI 1497737373
$24,589.81
in general payments reported to CMS, 2019-2025
17 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $60.34 · 2021: $285 · 2022: $403 · 2024: $11K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $963 · Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,623.33 |
| Travel and Lodging | $963.07 |
| Food and Beverage | $110.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $22,826.92 | 2021-2025 | Wallach Cryosurgical Equipment, Mityone, Wallach |
| Applied Medical Resources Corporation | $1,073.21 | 2025 | |
| Fujirebio Diagnostics, Incorporated | $350.00 | 2022 | |
| Alydia Health | $81.82 | 2021 | |
| Coloplast Corp | $50.53 | 2019-2020 | |
| Sage Therapeutics, LLC | $40.12 | 2022 | |
| Pfizer INC. | $25.26 | 2019 | |
| Astellas Pharma US INC | $24.39 | 2019 | |
| Minerva Surgical, INC | $22.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.60 | 2020 | |
| Hologic Sales and Service, LLC | $16.32 | 2019 | |
| Abbvie INC. | $15.71 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.07 | 2019 | |
| Allergan, INC. | $12.55 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $12.53 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Neiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.